PEKOS, PETER — Insider Profile

Insider Profile

PEKOS, PETER

$CRDL

Companies Filed At

Open-Market Buys (2yr)

$50K

Buy Value (2yr, open-market)

Dec 30, 2025

Most Recent Trade

Credibility
Score

Hit Rate

-18.8%

Avg 90d Return

-11.9%

Median 90d Return

Evaluated Trades

-0.3%

Best Trade

-51.8%

Worst Trade

Hit rate and returns are based on 7 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Dec 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	15,594	—	—	45
Dec 03, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	60,000	$1.40	$84K	45
Sep 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	14,318	—	—	45
Dec 17, 2024	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	38,750	$1.29	$50K	45
Jul 10, 2024	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	100,000	—	—	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	68,157	$1.41	$96K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	68,157	$1.41	$96K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Expiry	Sell	60,000	$5.00	$300K	45
Jun 04, 2020	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	20,000	$0.22	$4K	45
Jun 04, 2020	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	40,000	$2.39	$96K	45

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.